This post was originally published on this site
Cantor Fitzgerald initiated coverage on Palo Alto Networks (NASDAQ:PANW) with an Overweight rating and a price target of $220. The analysts called it the most comprehensive next-gen security platform. Shares rose 2%.
Jefferies assumed coverage on Teva Pharma (NYSE:TEVA) with a Buy rating and a price target of $10, saying the recent opioid settlement better enables it to get “back to business.” Shares gained 4% today.
UBS initiated coverage on Bruker (NASDAQ:BRKR) with a Buy rating and a price target of $70, saying it is positioned to grow revenues faster than the historic average and consensus. Further, they see tailwinds from the CHIPS and Science Act. Shares gained 3.5%.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
